Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2016 by Vanderbilt-Ingram Cancer Center
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Christine Lovly, MD, PhD, Vanderbilt-Ingram Cancer Center
ClinicalTrials.gov Identifier:
NCT00897650
First received: May 9, 2009
Last updated: July 19, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2019 (Final data collection date for primary outcome measure)